Compare GE Vernova Inc (GEV) vs Heron Therapeutics Inc (HRTX) Price & Performance

GE Vernova IncTrade

Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

GE Vernova Inc vs Heron Therapeutics Inc — how do they compare? GE Vernova Inc trades at $1,051 (market cap $269.50B), while Heron Therapeutics Inc trades at $0.33 (market cap $61.47M). The key difference: GE Vernova Inc is far larger — about 4384.3× Heron Therapeutics Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

	GEV	HRTX
Market Cap	$269.50B	$61.47M
Sector	Technology	Health
52-Week High	$1.17K	$1.49
52-Week Low	$547.96	$0.32
Enterprise Value	$259.17B	$168.21M
Dividend Yield	0.2%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GEV

GE Vernova benefits from AI-driven power and grid bottlenecks but faces high expectations at 28x 2028 earnings.Seeking Alpha · 9 hours agoNeutral Invesco S&P 500 Equal Weight Energy ETF rated Buy for balanced energy sector exposure amid oil market shifts.Seeking Alpha · 2 days agoBullish View details →

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.